Concepedia

Iris D. Gersten

ID

Statistics

Publications

8

Citations

983

H-Index

8

Active since

2007

Affiliations

Emmes (United States)(Current)

Medical College of Wisconsin

Duke University

Dana-Farber Cancer Institute

National Marrow Donor Program

Iris D. Gersten is an author at Emmes (United States) specializing in marrow transplantation, transplantation, and hematology.

Top concepts

Publications per year

2007–2018

8

Publications

8

Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation

John R. Wingard, Shelly L. Carter, Thomas J. Walsh et al. · Blood · 2010 · 470 citations · Full text

A trial of unrelated donor marrow transplantation for children with severe sickle cell disease

Shalini Shenoy, Mary Eapen, Julie A. Panepinto et al. · Blood · 2016 · 206 citations · Full text

Results of a Randomized, Double-Blind Trial of Fluconazole (FLU) vs. Voriconazole (VORI) for the Prevention of Invasive Fungal Infections (IFI) in 600 Allogeneic Blood and Marrow Transplant (BMT) Patients.

John R. Wingard, Shelly L. Carter, Thomas J. Walsh et al. · Blood · 2007 · 91 citations

Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1–2 dose de-escalation study

Paolo Anderlini, Juan Wu, Iris D. Gersten et al. · The Lancet Haematology · 2015 · 79 citations · Full text

, , +10

Fludarabine-Based Conditioning for Marrow Transplantation from Unrelated Donors in Severe Aplastic Anemia: Early Results of a Cyclophosphamide Dose Deescalation Study Show Life-Threatening Adverse Events at Predefined Cyclophosphamide Dose Levels

Jakub Tolar, H. Joachim Deeg, Sally Arai et al. · Biology of Blood and Marrow Transplantation · 2012 · 52 citations · Full text

, , +7

1–5 of 8